Active Apolipoprotein C1 (APOC1)

Apo-C1; Truncated apolipoprotein C-I

ACTIVITY TEST

Apolipoprotein C1 (APOC1), also known as Apo-CI; ApoC-I; apo-CIB; apoC-IB, is the smallest size apolipoprotein  of all apolipoprotein C family (Mr = 6.6 kDa) and located at position 19q13.32. APOC1 is primarily expressed in the liver and activated when monocytes differentiate into macrophages. It plays important roles in the innate immune response as effector of glucocorticoid-mediated responses and regulator of the inflammatory process. It has anti-inflammatory activity and also can promote the differentiation of T-cells into Th1 cells and negatively regulates differentiation into Th2 cells. Besides, Apolipoprotein A1 (APOA1) has been identified as an interactor of APOC1, thus a functional binding ELISA assay was conducted to detect the interaction of recombinant human APOC1 and recombinant human APOA1. Briefly, APOC1 was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to APOA1-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-APOC1 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 µL stop solution to the wells and read at 450/630 nm immediately. The binding activity of recombinant human APOC1 and recombinant human APOA1 was shown in Figure 1, the EC50 for this effect is 0.46 ug/mL.

USAGE

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
PROTEOMICS - Clinical Applications Proteomic and genomic analyses suggest the association of Apolipoprotein C1 with abdominal aortic aneurysm Onlinelibrary: prca.201300119
Journal of Dairy Science Colostrum and milk protein rankings and ratios of importance to neonatal calf health using a proteomics approach pubmed:28189329
RESPIRATORY RESEARCH The HDL from septic-ARDS patients with composition changes exacerbates pulmonary endothelial dysfunction and acute lung injury induced by cecal ligation … Pubmed: 33148285
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA252Hu01 Recombinant Apolipoprotein C1 (APOC1) Positive Control; Immunogen; SDS-PAGE; WB.
APA252Hu01 Active Apolipoprotein C1 (APOC1) Cell culture; Activity Assays.
APA252Hu02 Active Apolipoprotein C1 (APOC1) Cell culture; Activity Assays.
RPA252Hu02 Recombinant Apolipoprotein C1 (APOC1) Positive Control; Immunogen; SDS-PAGE; WB.
PAA252Hu01 Polyclonal Antibody to Apolipoprotein C1 (APOC1) WB; IHC; ICC/IF; FCM
PAA252Hu02 Polyclonal Antibody to Apolipoprotein C1 (APOC1) WB; IHC; ICC; IP.
LAA252Hu71 Biotin-Linked Polyclonal Antibody to Apolipoprotein C1 (APOC1) WB; IHC; ICC.
MAA252Hu21 Monoclonal Antibody to Apolipoprotein C1 (APOC1) WB
MAA252Hu23 Monoclonal Antibody to Apolipoprotein C1 (APOC1) WB; IHC; ICC; IP.
MAA252Hu22 Monoclonal Antibody to Apolipoprotein C1 (APOC1) WB; IHC; ICC; IP.
FAA252Hu02 Anti-Apolipoprotein C1 (APOC1) Monoclonal Antibody FCM
FAA252Hu04 Anti-Apolipoprotein C1 (APOC1) Monoclonal Antibody Flow cytometry.
SEA252Hu ELISA Kit for Apolipoprotein C1 (APOC1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA252Hu Multiplex Assay Kit for Apolipoprotein C1 (APOC1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
CGA252Hu02 cDNA of Apolipoprotein C1 (APOC1) PCR; Protein Expression; etc.